2024
Discordance Between Insurance Coverage of Antiviral Medications and Nicotine Replacement Therapy Among Individuals With Human Immunodeficiency Virus Who Smoke
Bernstein S, Yager J, Sigel K, Porter E, Do T, Payne E, Bold K, Ledgerwood D, Edelman E. Discordance Between Insurance Coverage of Antiviral Medications and Nicotine Replacement Therapy Among Individuals With Human Immunodeficiency Virus Who Smoke. Journal Of Addiction Medicine 2024, 18: 404-407. PMID: 38606851, PMCID: PMC11290992, DOI: 10.1097/adm.0000000000001302.Peer-Reviewed Original ResearchNicotine replacement therapyHuman immunodeficiency virusTobacco use disorderAntiretroviral therapyReplacement therapyTobacco useImmunodeficiency virusCoverage of antiretroviral therapyInsurance coverageSecondary analysis of dataUse disorderManaged care planOut-of-pocketMandated insurance coverageCare planningEfficacy of antiviralsRandomized clinical trialsPharmacy benefit managersInsurance barriersMedication prescriptionsSecondary analysisTracking formParticipation AssessmentAntiviral medicationsPWH
2023
Facilitation and Preferred Models for Delivering Substance Use Disorder Treatment in HIV Clinics: Results From a Multisite Randomized Trial
Muvvala S, Gan G, Morford K, Dziura J, Esserman D, Porter E, Chan P, Cornman D, Reynolds J, Yager J, Fiellin D, Edelman E. Facilitation and Preferred Models for Delivering Substance Use Disorder Treatment in HIV Clinics: Results From a Multisite Randomized Trial. Journal Of Addiction Medicine 2023, 17: e388-e391. PMID: 37934538, PMCID: PMC10726383, DOI: 10.1097/adm.0000000000001192.Peer-Reviewed Original ResearchConceptsOpioid use disorderAlcohol use disorderTobacco use disorderHIV clinicUse disordersAddiction treatmentSubstance use disorder treatmentUse disorder treatmentMaintenance phaseRandomized trialsStaff preferencesImproved outcomesMultisite Randomized TrialImplementation facilitationDisorder treatmentControl phaseClinicCliniciansTreatment modelTreatmentDisordersSignificant differencesInterventionHigher proportionAddiction treatment models